SCHEMBL6972771

SCHEMBL6972771

O=C(N[C@H]1CCN(C(=O)c2ccc3ccccc3n2)C1)[C@@H]1CCCCN1c1nc2ccccc2o1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
LMNA P02545 3/20 0.48
TSHR P16473 2/20 0.48
HTT P42858 2/20 0.48
MAPT P10636 1/20 0.48
HCRTR1 O43613 3/20 0.46
HCRTR2 O43614 3/20 0.46
SCN9A Q15858 1/20 0.40
KDM5A P29375 6/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
ELANE P08246 2/20 0.38
KDM5B Q9UGL1 1/20 0.38
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965850 0.85 HCRTR1 (0.50) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL7680423 0.83 LMNA (0.58) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL7083455 0.82 LMNA (0.47) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6975896 0.81 HCRTR1 (0.47) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6975687 0.81 LMNA (0.43) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6973405 0.81 HCRTR1 (0.52) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6979417 0.80 KDM4E (0.50) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6975277 0.79 LMNA (0.48) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6966984 0.78 LMNA (0.50) SMN1; SMN2LMNATSHRHTTMAPT
SCHEMBL6968264 0.78 OPRK1 (0.56) SMN1; SMN2LMNATSHRHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP claimed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US claimed
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed